I am a
Home I AM A Search Login

Papers of the Week

Papers: 2 Jan 2021 - 8 Jan 2021

Human Studies, Pharmacology/Drug Development


2021 Jan 04

Expert Opin Drug Saf

A long-term open-label safety study of galcanezumab in Japanese patients with migraine.


Hirata K, Takeshima T, Sakai F, Tatsuoka Y, Suzuki N, Igarashi H, Nakamura T, Ozeki A, Yamazaki H, Skljarevski V
Expert Opin Drug Saf. 2021 Jan 04:1-13.
PMID: 33393835.


Because of the burden of migraine in Japan, there is a need for safe and effective preventive treatments. This study assessed the long-term safety and tolerability of galcanezumab in Japanese patients with episodic (EM) or chronic (CM) migraine.